TevaExecutive Yitzhak Peterburg Claims Health Care Industry Is Facing Heavy Disruption
Teva Names Interim CEO, New Chairman As Vigodman Steps Down
Kåre Schultz new CEO of Teva - Nordic Life Science – the leading Nordic life science news service
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Teva CEO Erez Vigodman steps down - Philadelphia Business Journal
Teva elects Yitzhak Peterburg as chairman | Careers | POST Online Media
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Chaim Hurvitz: Peterburg preferable as Teva chairman - Globes
Teva Sells IUD Business for $1.1 Billion | Ctech
Teva Pharmaceuticals - Wikiwand
Teva's Yitzhak Peterburg steps down - Globes
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
Former Chairman Yitzhak Peterburg Leaves Teva | Ctech
Teva CEO Erez Vigodman unexpectedly resigns effective immediately
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva CEO exits in ongoing crisis of confidence at drugmaker | Reuters
Teva under police investigation in home market of Israel | Financial Times
Teva Pharmaceutical CEO says health-care is facing 'huge disruption'
Teva's Perfect Storm Sends Tel-Aviv Stock Exchange Down | Ctech
1 Scale-up the Start-up Nation Prof. Yitzhak Peterburg, Chairman of the Board, Teva Pharmaceutical Industries Ltd. 8 June 2015 The People of Israel. - ppt download
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals - Wikiwand
Teva Pharmaceuticals Q4 2016 Earnings
Teva CEO Erez Vigodman steps down - CDR – Chain Drug Review
